vision sciences inc. ( nasdaq : vsci ) is an international endoscopy product manufacturer and supplier .

it was founded in 1987 by lewis c. pell and katsumi oneda and is based in orangeburg , new york .

in december 2013 , the company has been selected by 21st century oncology inc. as 21st century ’s preferred vendor of choice and its products will be applied in medical treatment in a variety of therapeutic areas including cancer care .

vision sciences inc .

vision - sciences inc . ; vision - sciences , inc . announces new executive vice - president and chief financial officer
vision - sciences , inc . tne system offers solution for sedation concerns | biospace
vision - sciences , inc . ron hadani , ceo 845 - 365 - 0600
vision - sciences inc . ; vision - sciences , inc . announces new executive vice - president and chief financial officer - abn newswire ( @ abn _ newswire )
vision - sciences , inc . announces new executive vice - president and chief financial officer
. . . - for - stock merger of pell’s vision - sciences inc . and rob kill’s uroplasty inc . after the merger . . .
contact : vision - sciences , inc . christian escobar , marketing manager 845 - 365 - 0600
vision - sciences owns the registered trademarks vision sciences® , endosheath® , endowipe® , slide - on® , and the vision system® .
vision - sciences , inc . announces new executive vice - president and chief financial officer nasdaq : vsci
vision - sciences , inc . announces election of new director - business - press releases | nbc news
. . . inc . and vision - sciences inc . as a result of which the former uroplasty stockholders held 62 . 5 percent of . . .
vision‑sciences owns the registered trademarks vision sciences ® , slide - on ® , endosheath ® and the vision system ® . information about vision - sciences ' products is available at urltoken .
contact : vision - sciences , inc . ron hadani , ceo + 1 - 845 - 365 - 0600
vision - sciences , inc . receives ce clearance and health canada approval to market its video - based advanced endoscopy lines
contact : vision - sciences , inc . katherine wolf , cfo & evp , corporate development ( 845 ) 365 - 0600
. . . achieve those goals . the drama stems from the march 2015 merger of pell’s vision - sciences inc . . .
, vision - sciences , inc . designs , develops , manufactures and markets products for flexible endoscopy . the company ' s unique product lines feature a streamlined visualization system and proprietary sterile disposable microbial barrier , known as endosheath technology , providing users with efficient and cost effective endoscope turnover while enhancing patient safety . for more information on vision - sciences and its products , please visit vision - sciences , inc . at
terms of service | privacy policy | © 2018 crunchbase inc . all rights reserved .
signature mapping medical sciences , inc . ( smms ) is a wholly - owned subsidiary focused on the development of computer vision automated medical diagnostic and decision support software solutions .
in connection with the proposed merger , vision - sciences plans to file with the sec a registration statement on form s - 4 that will include a joint proxy statement of uroplasty and vision - sciences that also constitutes a prospectus of vision - sciences . uroplasty and vision - sciences will make the joint proxy statement / prospectus available to their respective shareholders .
vision - sciences , inc . ( nasdaq : vsci ) develops , manufactures and markets unique flexible endoscopic products for a variety of markets . for more information , please visit us at urltoken
vision - sciences , inc . ( nasdaq : vsci ) develops , manufactures and markets unique flexible endoscopic products for a variety of markets . for more information , please visit us at urltoken
vision - sciences , inc . designs , develops , manufactures and markets products for flexible endoscopy . the company ' s unique product lines feature a streamlined visualization system and proprietary sterile , disposable microbial barrier , known as endosheath® technology , providing users with efficient and cost effective endoscope turnover while enhancing patient safety . information about vision - sciences ' products is available at urltoken .
by internet : under the
investors
tabs at the uroplasty website at urltoken and vision - sciences website at urltoken .
orangeburg , n . y . , dec . 15 , 2010 ( globe newswire ) - - vision - sciences , inc . , ( nasdaq : vsci ) ( vision - sciences ) , announced today that its board of directors elected dr . bruce polsky to serve as a member of its board , effective immediately . dr . polsky will be an independent member of the board .
orangeburg , n . y . , june 3 , 2008 ( prime newswire ) - - vision - sciences , inc . , ( nasdaq : vsci ) (
vision - sciences
) , announced today that it received approval from underwriters laboratories inc . to affix the ce mark to its new line of advanced digital , video - based flexible endoscopes , which come with an integrated
built - in
light source , eliminating the need for a separate camera head , light cable and optical coupler . vision - sciences also announced health canada approval for these scopes . with health canada ' s approval , and the approval of applicable technical files and updated ec certificates , vision - sciences is now permitted to distribute and sell its scopes throughout all eu countries and canada .
, vision - sciences ' chairman . these notes and warrants have been amended in connection with the merger , as described below .
vision sciences , a medical device company , develops flexible endoscopes as a control solution to decrease the risk of cross - contamination .
vision - sciences , inc . designs , develops , manufactures and markets unique flexible endoscopic products utilizing sterile disposable sheaths , the slide - on ® endosheath ® technology , which provide the users quick , efficient product turnover while ensuring the patient a contaminant - free product .
is acting as exclusive financial advisor to uroplasty . leerink partners is acting as exclusive financial advisor to vision - sciences . oppenheimer wolff & donnelly llp is acting as counsel for uroplasty , and royer cooper cohen braunfeld llc is acting as counsel for vision - sciences .
orangeburg , n . y . , sept . 16 , 2008 ( globe newswire ) - - vision - sciences , inc . ( nasdaq : vsci ) today announced that katherine wolf has been named as the company ' s executive vice - president , corporate development and chief financial officer , effective today . in this role she will be responsible for all of vision - sciences ' financial operations and business development activities .
orangeburg , n . y . , sept . 16 , 2008 ( globe newswire ) - - vision - sciences , inc . ( nasdaq : vsci ) today announced that katherine wolf has been named as the company ' s executive vice - president , corporate development and chief financial officer , effective today . in this role she will be responsible for all of vision - sciences ' financial operations and business development activities .
vision - sciences , inc . and its subsidiaries designs , develops , manufactures , and markets products for endoscopy - the science of using an instrument , known as an endoscope , to provide minimally invasive access to areas not readily visible to the human eye . our products are sold throughout the world
gilead sciences , inc . is a research - based biopharmaceutical company that discovers , develops and commercializes innovative medicines in areas of unmet medical need . we strive to transform and simplify care for people with life - threatening illnesses around the world .
vision - sciences , inc . ( nasdaq : vsci ) develops , manufactures and markets unique flexible endoscopic products for the urology , gastroenterology and the ent markets , utilizing the proprietary sterile disposable endosheath ( r ) technology . this technology provides quick and efficient equipment turnover , and ensures the patient a contaminant - free endoscope insertion .
i am excited to join a company with such great potential ,
said ms . wolf .
i think vision - sciences ' technology and management creates a tremendous opportunity . i look forward to joining the rest of the team as we implement vision - sciences ' financial , business development and operational strategies .
i am extremely pleased to welcome bruce to the board . his extensive medical background and knowledge of infectious diseases add significantly to our organization ,
said lewis pell , chairman of vision - sciences . dr . polsky was elected as a class ii director , to serve until vision - sciences ' 2011 annual shareholders ' meeting . dr . polsky was nominated to be reelected to the board at vision - sciences ' annual shareholders ' meeting , expected to be held in september 2011 .
copyright © 2014 applied visual sciences , all rights reserved . terms of use |
guardian technologies international , inc . ( gdti ) is a wholly - owned subsidiary focused on the development of automated target recognition software solutions for the homeland security and military marketplaces .
following the closing of the transaction , which is expected to occur during the first half of 2015 , the combined company will conduct business as cogentix medical , inc . ( nasdaq :
) and from uroplasty and vision - sciences . requests for copies of the joint proxy statement / prospectus and other documents filed by uroplasty with the sec may be made by contacting
, as well as both companies ' subsequent quarterly reports on form 10 - q and other information filed by each company with the sec . uroplasty and vision - sciences caution investors not to place considerable reliance on the forward - looking statements contained in this press release . you are encouraged to read uroplasty ' s and vision - sciences ' filings with the sec , available at
the merger of uroplasty and vision - sciences will create a medical device company positioned for growth with proprietary , innovative technologies serving the urology market . in addition to the minimally - invasive urgent pc and macroplastique product lines , uroplasty ' s 44 person u . s . sales organization , along with vision - sciences ' 12 person u . s . sales organization , will aggressively market vision - sciences ' proprietary endosheath technology platform . internationally , the combined company ' s products will be sold through uroplasty ' s eight direct sales representatives as well as the current distributors of both companies .
uroplasty , vision - sciences , their respective directors , executive officers and employees may be deemed to be participants in the solicitation of proxies from uroplasty ' s and vision - sciences ' respective shareholders in connection with the proposed transaction . information about the directors and executive officers of uroplasty and their ownership of uroplasty stock is set forth in uroplasty ' s annual report on form 10 - k for the fiscal year ended
. these documents can be obtained free of charge from the sources indicated above . certain directors , executive officers and employees of uroplasty and vision - sciences may have direct or indirect interest in the transaction due to securities holdings , vesting of equity awards and rights to severance payments . additional information regarding the participants in the solicitation of uroplasty and vision - sciences shareholders will be included in the joint proxy statement / prospectus filed with the sec .
, 2015 . once the existing uroplasty sales team is fully trained on the vision - sciences ' product line , the new company is expected to achieve sustainable annual revenue growth of 15 % beginning with its second fiscal year .
katherine has tremendous experience in healthcare investment banking and finance , which will be invaluable to vision - sciences as we continue to expand the applications for our technologies ,
said ron hadani , president and ceo of vision - sciences .
her background in capital markets , her reputation among the financial community and a deep understanding of our business make her uniquely qualified to help us expand on opportunities to capitalize on our revolutionary videoscope and other new technologies .
under the terms of the agreement , which was unanimously approved by the boards of directors of both companies , each outstanding share of uroplasty ' s common stock will be exchanged for 3 . 6331 shares of vision - sciences ' common stock . upon completion of the merger , uroplasty shareholders will own 62 . 5 % of the shares of the combined company on a fully - diluted basis , and vision - sciences shareholders will own 37 . 5 % . [ 1 ]
, who will become senior vice president of global sales and marketing . cogentix medical ' s board of directors will be comprised of the five representatives from uroplasty ' s existing board and three representatives from vision - sciences ' existing board .
, for a discussion of these and other risks and uncertainties . the forward - looking statements in this press release speak only as of the date of this release , and uroplasty and vision - sciences undertake no obligation to update or revise any of these statements . uroplasty ' s and vision - sciences ' businesses are subject to substantial risks and uncertainties , including those referenced above . investors , potential investors , and others should give careful consideration to these risks and uncertainties .
, president and ceo of uroplasty .
we are confident that offering vision - sciences ' urology product lines to our core urology customer base will also make us more meaningful and valuable to those customers . at the same time , we expect that the increased focus by care providers on endoscopic efficiency and prevention of cross - contamination creates significant growth opportunity for vision - sciences ' endosheath technology in adjacent markets such as ent and pulmonology . with more than five million units sold and zero reported cases of cross contamination , we believe that endosheath products will be the standard of care for endoscopic applications , and our team fully intends to turn this efficacy leadership into market leadership . we look forward to working with the vision - sciences ' team to enhance shareholder value through this combination .
vision - sciences ' new digital scopes employ our proprietary endosheath ( r ) technology . unlike endoscopes from other manufacturers , vision - sciences ' new advanced video scopes do not contain difficult - to - clean operating channels . instead , our video scopes utilize our patented , disposable , sterile slide - on ( r ) endosheath ( r ) technology which covers the entire endoscope . each disposable sheath contains a sterile operative channel , which eliminates patient tissue or organic matter from coming into contact with the reusable endoscope or the next patient .
dr . polsky commented ,
i am delighted to join the board of vision - sciences . i believe the company ' s endosheath technology for flexible endoscopy is unique , providing sterile , efficient endoscopic procedures without the traditional complexities and difficulties associated with conventional endoscopy .
the named executive officers and directors of each company , representing approximately 4 . 2 % and 39 . 1 % of uroplasty ' s and vision - sciences ' outstanding common stock respectively , evidenced their support by entering into voting agreements to vote in favor of the transaction .
cogentix medical , inc . , formerly vision - sciences , inc . , is a medical device company . the company designs , develops , manufactures and markets products for endoscopy with its product lines featuring a visualization system and sterile disposable microbial barrier , endosheath technology . the company produces and markets endoscopes , such as cystoscopes , ureteroscopes , laryngoscopes , otoscopes , sinuscopes , trans - nasal esophagoscopy ( tne ) and bronchoscopes for medical use and borescopes for industrial use , and digital processing units ( dpu ) . the company offers urgent pc neuromodulation system , a nerve stimulation device that delivers percutaneous tibial nerve stimulation ( ptns ) for the office - based treatment of overactive bladder ( oab ) . it also offers macroplastique , an injectable , urethral bulking agent for the treatment of adult female stress urinary incontinence . it markets additional bulking agents : ptq for the treatment of fecal incontinence and the vox for vocal cord augmentation .
orangeburg , n . y . , oct . 27 , 2014 ( globe newswire ) - - the report by the new york city office of the chief medical examiner on the death of joan rivers points to a
predictable complication of medical therapy .
vision - sciences ( nasdaq : vsci ) believes one solution to these complications is a sedation - free exam for the patient . the vision sciences® tne endoscopy system with patented endosheath® technology offers physicians the ability to visualize , diagnose , and treat a patient ' s upper airway , throat , esophagus , and stomach without the need for the complications of sedation .
we are very excited to be able to begin shipping orders to our european and canadian customers ,
stated ron hadani , president and chief executive officer vision - sciences .
we will now be able to meet the medical community ' s overwhelming interest in our products , and expand our opportunities in the european and canadian markets .
a key necessity in stopping the growth of esophageal cancer is a safe , cost - effective , efficient diagnostic option for physicians ,
stated howard zauberman , president and chief executive officer of vision - sciences .
we believe our tne system combined with our endosheath technology provides the ideal instrument for the mounting need in diagnosing and managing esophageal disorders .
since joining vision - sciences in 2006 , mr . yoav m . cohen has served as our chief financial officer and until april 2008 , as our acting chief operating officer . mr . cohen is returning to nyc advisors , llc , a financial advisory firm located in white plains , new york , as its managing partner , and will continue to devote his time and substantial efforts working closely with us on accounting and financial projects .
yoav has provided outstanding support to vision - sciences , as we continue to grow ,
said mr . hadani .
under yoav ' s leadership and guidance , we have updated and modernized our accounting , financial and operational systems , and we look forward to his continued contribution .
the vision - sciences innovative endoscopy technology and the transnasal approach avoid the use of propofol sedation , allowing patients to undergo the diagnostic exam while alert and awake . due to the small size of the tne system , the endoscope can be comfortably passed through the nasal passage instead of through the mouth , avoiding the patient gag reflex – a significant factor in the requirement for sedation in traditional oral exams .
, chairman of vision - sciences , commented ,
during the past several months as we have evaluated the combination of our two companies , we have been thoroughly impressed by uroplasty ' s senior management team and distribution platform . they achieved notable growth with the urgent pc system , and we believe under uroplasty ' s leadership , that our shareholders have the best opportunity to generate value through maximizing the global market potential for the combined company ' s product lines and proprietary technology .
vision - sciences is currently the only provider of an fda - cleared line of transnasal endoscopes for this procedure that utilizes the patented endosheath technology , a cost - effective and safe solution for patients , doctors , hospitals , and other medical facilities . with endosheath technology , the tne endoscope is placed inside a new , sterile cover for each exam . the sheath is discarded after each procedure , guarding against the potential of an unclean endoscope and the risk of bacterial or viral cross - contamination with the next patient .
the transaction is expected to qualify as a tax free reorganization under the internal revenue code . the transaction is subject to customary closing conditions , including approval of the shareholders of each of uroplasty and vision - sciences . in connection with this transaction , the convertible promissory notes held by mr . pell will be amended . the maturity date of the amended notes will be five years from the date of the closing the merger , and interest accrued under the notes shall be calculated quarterly and payable on the maturity date or upon repayment or conversion of all or any portion of the principal . in addition , the notes will not be convertible until the third anniversary of the closing , except in a change in control or if the company decides to prepay the notes . vision - sciences and mr . pell also agreed to extend the period during which he may exercise his warrants , which will be exercisable starting on the third anniversary of the closing and ending on the later of the maturity date of the convertible promissory notes or the date on which the notes are converted or paid in full . the warrants would also be exercisable in the event of a change in control .
, is a global medical device company that develops , manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions . uroplasty ' s focus is the continued commercialization of its urgent® pc neuromodulation system , which uroplasty believes is the only commercially available , fda - cleared device that delivers percutaneous tibial nerve stimulation ( ptns ) for the office - based treatment of overactive bladder ( oab ) . oab is a chronic condition that affects approximately 42 million u . s . adults . the symptoms include urinary urgency , frequency and urge incontinence . uroplasty also offers macroplastique® , an injectable urethral bulking agent for the treatment of adult female stress urinary incontinence primarily due to intrinsic sphincter deficiency . for more information on uroplasty and its products , please visit uroplasty , inc . at
this release includes forward - looking statements intended to qualify for the safe harbor from liability established by the private securities litigation reform act of 1995 . these forward - looking statements generally can be identified by phrases such as vision - sciences or its management
believes ,
expects ,
allows ,
anticipates ,
or other words or phrases of similar import . similarly , statements in this release that describe our business strategy , outlook , objectives , plans , intentions or goals also are forward - looking statements . all such forward - looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward - looking statements . other risk factors are detailed in our most recent annual report and other filings with the sec .
this release includes forward - looking statements intended to qualify for the safe harbor from liability established by the private securities litigation reform act of 1995 . these forward - looking statements generally can be identified by phrases such as vision - sciences or its management
believes ,
expects ,
allows
,
anticipates ,
or other words or phrases of similar import . similarly , statements in this release that describe our business strategy , outlook , objectives , plans , intentions or goals also are forward - looking statements . all such forward - looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward - looking statements . other risk factors are detailed in our most recent annual report and other filings with the sec .
ms . wolf has an extensive background in finance and the health care industry . before joining vision - sciences , ms . wolf was a managing director at hsbc in its investment banking division where she was a founding member of the firm ' s health care group . ms . wolf was responsible for leading the investment banking global medical technology effort , including origination and execution of m & a and corporate finance transactions . while at hsbc , ms . wolf was also a managing director in the firm ' s financial sponsors group . prior to hsbc , she was a managing director in the health care group at bear stearns & co . , and before that , at sg cowen and furman selz . ms . wolf holds an m . b . a . from harvard business school and a b . a . from williams college .
ms . wolf has an extensive background in finance and the health care industry . before joining vision - sciences , ms . wolf was a managing director at hsbc in its investment banking division where she was a founding member of the firm ' s health care group . ms . wolf was responsible for leading the investment banking global medical technology effort , including origination and execution of m & a ; and corporate finance transactions . while at hsbc , ms . wolf was also a managing director in the firm ' s financial sponsors group . prior to hsbc , she was a managing director in the health care group at bear stearns & co . , and before that , at sg cowen and furman selz . ms . wolf holds an m . b . a . from harvard business school and a b . a . from williams college .
except for the historical information provided , the matters discussed in this release include forward - looking statements for the purposes of the safe harbor protections under the private securities litigation reform act of 1995 . these forward - looking statements generally can be identified by phrases such as vision - sciences or its management
believes ,
expects ,
allows ,
anticipates ,
or other words or phrases of similar import . similarly , statements in this release that describe our business strategy , outlook , objectives , plans , intentions , or goals are also forward - looking statements . all such forward - looking statements are subject to certain risks and uncertainties that could cause our actual results to differ materially from those in forward - looking statements . other risk factors are detailed in our most recent annual report and other filings with the securities and exchange commission . we do not assume any obligation to update any forward - looking statements as a result of new information or future events or developments .
this press release includes forward - looking statements . these forward - looking statements generally can be identified by the use of words such as
anticipate ,
expect ,
plan ,
could ,
may ,
will ,
believe ,
estimate ,
forecast ,
goal ,
project ,
and other words of similar meaning . forward - looking statements in this press release include , but are not limited to , statements about the benefits of the transaction ; expected revenue growth rates ; the expected timing of the completion of the transaction ; and the combined company ' s plans , objectives , expectations and intentions with respect to future operations , products and services . each forward - looking statement contained in this press release is subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statement . applicable risks and uncertainties include , among others , uncertainties as to the timing of the transaction ; uncertainties as to whether uroplasty shareholders and vision - sciences shareholders will approve the transaction ; the risk that competing offers will be made ; the possibility that various closing conditions for the transaction may not be satisfied or waived ; the risk that shareholder litigation in connection with the transaction may result in significant costs of defense , indemnification and liability ; other business effects , including the effects of industry , economic or political conditions outside of either company ' s control ; the failure to realize synergies and cost - savings from the transaction or delay in realization thereof ; the businesses of uroplasty and vision - sciences may not be combined successfully , or such combination may take longer , be more difficult , time - consuming or costly to accomplish than expected ; operating costs and business disruption following completion of the transaction , including adverse effects on employee retention and on each company ' s respective business relationships with third parties ; transaction costs ; actual or contingent liabilities ; the adequacy of the combined company ' s capital resources ; and the risks identified under the heading
risk factors
in uroplasty ' s annual report on form 10 - k , for the fiscal year ended
please check your spelling . try our suggested matches or see results in other tabs .
for inquiries related to this message please contact support . for sales inquiries , please visit urltoken
if you believe this to be in error , please confirm below that you are not a robot by clicking
i ' m not a robot
below .
please make sure your browser supports javascript and cookies and that you are not blocking them from loading . for more information you can review the terms of service and cookie policy .
the spo profiles may contain historical records . please visit the latest spos for the most recent information .
unless otherwise indicated in the applicable prospectus supplement , we intend to use the net proceeds from the sale of the securities under this prospectus for general corporate purposes , including payment of expenses , working capital and repayment , in whole or in part , of outstanding indebtedness under our amended and restated loan agreement with lewis c . pell , the chairman of our board of directors ( the “loan agreement” ) dated as of september 30 , 2011 , and to otherwise meet the company’s liquidity needs . at this time , we have not determined the specific uses of any offering proceeds , or the amounts we plan to spend on any particular use or the timing of such expenditures . pending application of the net proceeds from any particular offering , we intend to invest such proceeds in short - term , interest - bearing , investment - grade securities . subject to the terms of the loan agreement , we may borrow an aggregate of up to $ 10 million , of which $ 8 . 0 million ( in accrued interest and principal ) is outstanding as of the date of this prospectus . under the loan agreement , we are required to apply ( i ) 100 % of the net proceeds from the sale of equity to a third - party to the amounts outstanding up to $ 5 million and ( ii ) ( a ) the applicable percentage ( defined below ) times ( b ) the amount of such proceeds in excess of $ 5 million , to repay outstanding amounts under the loan agreement . “applicable percentage” means 20 % upon receipt by the company of $ 5 million of net proceeds beyond the initial $ 5 million in net proceeds . this percentage increases on a straight line basis up to 100 % upon receipt of cumulative net proceeds to the company of at least $ 15 million . each time we issue securities , we will provide a prospectus supplement that will contain information about how we intend to use the proceeds from each such offering . we cannot guarantee that we will receive any proceeds in connection with any offering hereunder because we may choose not to issue any of the securities covered by this prospectus .
medical segment : competition we believe that the primary competitive benefits in the medical market for our flexible endoscopes and endosheath technology are safety and effectiveness , the optical quality of our product offering , product reliability , price , physician familiarity with the manufacturer and its products , ease of use and third - party reimbursement policies . our ability to compete is directly affected by several factors , such as our sales and marketing capabilities , our product development and innovation capabilities , our ability to obtain required regulatory clearances , our ability to protect the proprietary technology which our products are based upon , our manufacturing skills and our ability to attract and retain skilled employees . our current and future product lines face global competition , primarily from companies such as olympus , pentax , and karl storz . some of our competitors and some potential competitors may have greater financial resources , sales and marketing personnel and capabilities , research and development , and manufacturing personnel and capabilities than we do . in addition , any company that is able to significantly redesign conventional flexible endoscopes to simplify the disinfection process , or significantly improve the current methods of disinfecting flexible endoscopes , may result in competition for our products . we believe our proprietary endosheath technology platform currently allows us a significant differentiating factor from our competition . currently , all our competitors are selling endoscopes that require elaborate and time - consuming disinfection procedures . - - - industrial segment : competition in our industrial markets , we believe that our over 35 year history of product effectiveness , ease of use , product reliability and competitive pricing are the principal competitive factors to our success . among our competitors are olympus , ge inspection technologies , and karl storz industrial .
edgar® online , a division of donnelley financial solutions . edgar® is a federally registered trademark of the u . s . securities and exchange commission . edgar online is not affiliated with or approved by the u . s . securities and exchange commission .
enter up to 25 symbols separated by commas or spaces in the text box below . these symbols will be available during your session for use on applicable pages .
please note that once you make your selection , it will apply to all future visits to nasdaq . com . if , at any time , you are interested in reverting to our default settings , please select default setting above . if you have any questions or encounter any issues in changing your default settings , please email isfeedback @ urltoken .
you have selected to change your default setting for the quote search . this will now be your default target page ; unless you change your configuration again , or you delete your cookies . are you sure you want to change your settings ?
please disable your ad blocker ( or update your settings to ensure that javascript and cookies are enabled ) , so that we can continue to provide you with the first - rate market news and data you ' ve come to expect from us .
, where uroplasty ' s current headquarters is located . cogentix medical will be led by
endosheath endoscopy , which combines state - of - the - art endoscopic technology with a sterile , disposable microbial barrier , provides practitioners and healthcare facilities with a solution to meet the growing need for safe , efficient , and cost - effective flexible endoscopy . in addition to the combined company ' s increased presence in urology , the combination of the two companies will provide a platform for growth in other specialties that currently perform endoscopic procedures in hospitals and physician offices , which represents an addressable market opportunity of over
u . s . eastern standard time . this call can be accessed in three ways :
by telephone : for both
listen - only
participants and those who wish to take part in the question - and - answer portion of the call , the telephone dial - in number in the u . s . is ( 888 ) 806 - 6230 . for participants outside the u . s . , the dial - in number is ( 913 ) 312 - 0398 . the access code for all callers is 2077980 .
. the dial - in number for u . s . participants is ( 888 ) 203 - 1112 . for participants outside the u . s . , the replay dial - in number is ( 719 ) 457 - 0820 . the replay access code for all callers is 2077980 .
investors are urged to read the joint proxy statement / prospectus when it becomes available , because it will contain important information .
copyright © 2018 pr newswire association llc . all rights reserved . a cision company .
html public
- / / w3c / / dtd xhtml + rdfa 1 . 0 / / en
urltoken
enter your email address and name below to subscribe to any of our free e - newsletters .
sign up for a free crunchbase account to follow and track organizations you care about .
descriptive keyword for an organization ( e . g . saas , android , cloud computing , medical device )
this field describes an organization ' s most recent funding status ( e . g . early stage venture , late stage venture , m & a )
last funding round type ( e . g . series a , seed , private equity )
transaction name : auto - generated name of transaction ( e . g . angel - uber )
html public
- / / w3c / / dtd xhtml 1 . 0 transitional / / en
urltoken
this no - sedation method is a viable first line approach in diagnosing diseases of the esophagus . the lack of a need for sedation eliminates the risks and complications associated with sedation and physicians should be discussing this alternative to traditional endoscopy with their patients ,
stated howard siegel , m . d . , founding partner at manhattan internal medicine associates , p . c .
howard zauberman , president and chief executive officer , is available for in - person meetings or phone interviews . please contact mitch kayden at ( 845 ) 709 - 5607 or mkayden @ urltoken for more information or to set up an interview .
© 1985 - 2018 biospace . com . all rights reserved . powered by madgex job board software
distribution of company announcements to the professional platforms , finance portals and syndication of important corporate news to a wide variety of news aggregators and financial news systems .
globenewswire is one of the world ' s largest newswire distribution networks , specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media , investment community , individual investors and the general public .
we use cookies on this site to enable your digital experience . by continuing to use this site , you are agreeing to our cookie policy . close
data on cases , clients , outside counsel and individual attorneys collected from active federal civil cases . reflects only recently published court data ; not intended to be exhaustive . not responsible for errors in court dockets .
to view all the results and drill down deeper , take a free trial now .
gilead ' s portfolio of products and pipeline of investigational drugs includes treatments for hiv / aids , liver diseases , cancer , inflammatory and respiratory diseases , and cardiovascular conditions .
our portfolio of marketed products includes a number of category firsts , including complete treatment regimens for hiv infection available in a once - daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring hiv infection in certain high - risk adults .
collaborations of all kinds – with partners in science , academia , business and local communities – are central to our work . partnerships enhance our ability to develop innovative medicines and deliver them to people as efficiently as possible .
gilead was founded in 1987 in foster city , california . since then , we have grown to become one of the world’s largest biopharmaceutical companies , with more than 10 , 000 employees across six continents .
at gilead we are inspired by the opportunity to address unmet medical needs for patients living with life - threatening diseases around the world .
© 2009 - 2018 gilead . all rights reserved . terms of use | privacy statements | cookie statement
the origins of the institute for psychological research and application ( ipra ) can be traced back to 1981 . in 1981 an institute designed to provide consulting and research services to local and national organizations was created in the bgsu department of psychology . this institute was originally named the institute for organizational research and development ( iord ) . in 1987 , it was decided that the focus of iord was too narrowly defined and did not involve faculty from across the psychology department or the university . therefore , the department proposed to expand the mission of iord in its application for a state of ohio academic challenge award . the industrial / organizational psychology program received this competitive award in 1989 . as a result , the name iord was changed to ipra , and the institute became a broader - based organization open to intra and inter - departmental collaborative efforts so as to address and meet a diverse set of client needs for professional services . the goals of ipra are to :
since our inception , we have worked with a great number of clients . here is a partial list of our clients .
bgsu offers alternative versions of all of its pages for our users . you can select the high - contrast version below to persist throughout your bgsu website experience .
bowling green state university ( bgsu ) has built its website around the standards of the world wide web consortium ' s ( w3c ) hyper text markup language ( html ) 5 and cascading style sheets ( css ) . the website was built in compliance with the accessibility standards established by section 508 of the rehabilitation act and detailed in section 1194 . 22 of the code of federal regulations ,
web - based intranet and internet information and applications
( urltoken ) .
bgsu utilizes many webmasters across campus to maintain all of its web properties . keeping the bgsu website in compliance with section 508 is a joint effort between accessibility services , marketing and communications and information technology services . if any page is discovered to be inaccessible , please report it using the above link and we will ensure that the issue is addressed .
to our guests with disabilities , please indicate if you need special services , assistance or appropriate modifications to fully participate in this event by contacting accessibility services , access @ urltoken , 419 - 372 - 8495 . please notify us prior to the event .
html public
- / / w3c / / dtd html 4 . 01 / / en
urltoken
dr . polsky built an international reputation as an expert in infectious diseases at memorial sloan - kettering cancer center , where he also held the academic title of associate professor of medicine at cornell university medical college . dr . polsky is currently chairman of the department of medicine , chief of the division of infectious diseases , hospital epidemiologist and medical director of the clinical virology laboratory at st . luke ' s - roosevelt hospital center in new york city . dr . polsky also serves as the john h . keating sr . professor of clinical medicine at the college of physicians and surgeons of columbia university .
dr . polsky is a graduate of the university of michigan and the wayne state university school of medicine . his post - graduate training in internal medicine was at montefiore medical center and the albert einstein college of medicine in new york city , followed by a fellowship in infectious diseases at memorial sloan - kettering cancer center and cornell university medical college , where he joined the faculty upon completion of his training in 1986 , remaining until 1998 .
dr . polsky has been active in clinical investigations in hiv and infections complicating neoplastic disease and aids since the early 1980s . more recently , he has focused on the growing problem of hepatitis c and hepatitis b co - infection with hiv . a member of numerous medical societies in his field of specialty , dr . polsky has published over 200 peer - reviewed book chapters , research studies , clinical abstracts and professional journal articles .
microsoft named satya nadella on tuesday as its new chief executive officer . nadella , who joined the software company 22 years ago , replaces steve ballmer .
british pm : u . s . doesn’t want us to leave eu , putin does


simpich character dolls , ltd. was a dollmaker and home-workshop employer in colorado springs , colorado .

in production since 1952 , the founders , bob and jan simpich , announced their retirement for february 2007 , and the closing of their studio in the old colorado city historic commercial district .

the dolls themselves range from historical figures to mythological ones , and the most consistently popular are the christmas-themed dolls .

the dolls have spawned other concepts since their creation , notably the marionette theater of their son , puppeteer david simpich .

simpich character dolls

“laternchen” . simpich character dolls was started in 1952 by bob & joan simpich . simpich character dolls elf . simpich character dolls is very good .
simpich character dolls was started in 1952 by bob & joan simpich . simpich character dolls . ‘simpich originals’ halloween pumpkin girl . simpich character dolls is very good . the dolls were very limite . . .
simpich character dolls was started in 1952 by bob & joan simpich . simpich character dolls . simpich character dolls is very good . the dolls were very limited in production so the collectible market fo . . .
simpich character dolls was started in 1952 by bob & joan simpich . simpich character dolls elf . simpich character dolls is very good . “tumbleweed” . the dolls were very limited in production so the col . . .
simpich character dolls was started in 1952 by bob & joan simpich . simpich character dolls elf . simpich character dolls is very good . “balderdash” . the dolls were very limited in production so the col . . .
simpich character dolls was started in 1952 by bob & joan simpich . simpich character doll . simpich character dolls is very good . the dolls were very limited in production so the collectible market for . . .
simpich character dolls was started in 1952 by bob & joan simpich . simpich character doll elf . simpich character dolls is very good . “deacon” . the dolls were very limited in production so the collecti . . .
simpich character dolls was started in 1952 by bob & joan simpich . simpich character doll . this simpich doll which is apple girl ( girl giving apple ) is a hard one to find . simpich character dolls is v . . .
simpich doll grandpa ~ grandma . both are in excellent condition . they are no longer making the simpich dolls . christmas character dolls .
simpich character dolls was started in 1952 by bob & joan simpich . ‘simpich originals’ leprechaun with pot of gold . simpich character dolls . this one is in excellent condition , and a great deal . approx . . .
simpich dolls indian woman . beautiful woman in leather dress with beads and shells .
1987 geppetto simpich character doll . very rare . number 226 of 500 . excellent condition .
simpich characters dolls grandms 1989 carolers series . original handmade 12
. no original box .
this is howdoodle : a rare simpich character elf / doll . simpich elves were handmade in colorado springs , co at the iconic simpich gallery . the faces of these elves have great character - - each one diffe . . .
the simpich name in dolls is not completely going away . david simpich will continue the marionette theater he developed some 20 years ago , using simpich dolls as “actors . ” and , according to the catalog , the simpiches have created a “secondary market” on their website for buyers and sellers of their dolls .
beautiful simpich character doll depicting an old peasant woman carrying a basket of apples . among the most iconic simpich designs , the peasant woman was in constant production from 1952 until 2007 .
character dolls are made from original molds , like sculptures , but that ' s just the beginning . character dolls have to be painted , dressed and mounted , all of which require time and detailed individual effort . at simpiches , that has involved work in recent years by 45 trained employees .
simpich character dolls , which began as christmas presents for parents in 1952 when newlyweds bob and jan simpich were too broke to buy gifts , will close its doors saturday , dec . 23 ( although calls on previously placed orders will be taken until the early part of january ) .
these simpich carolers are part of phyllis murray’s collection on display at the montford inn , . many of these handmade dolls are 50 years old .
founded in 1952 by artists bob and jan simpich , the company known as simpich character dolls , ltd . , created iconic americana - style figurine dolls . the characters in their doll lines have included historical and mythological figures ; christmas - themed dolls like carolers , angels , and santas ; and even storybook figures such as tom sawyer , huck finn , alice in wonderland , pinocchio , and pecos bill . jan and bob retired in early 2007 , after closing . . .
pre - owned very good condition simpich character doll rare war cry salvation army lady 1990 # 666 / 1500 no original box high 12
thank you for looking .
pre - owned very good condition ( see the pictures ) simpich character doll street light lamp post . measures 19 1 / 2
tall light scratches . thank you for looking .
the simpich doll is authentically dressed and stands about 12” tall . very good condition .
for major repairs we can’t take care of , we will be happy to refer you to a simpich character doll restoration specialist who will work directly with you on the repair before it is consigned into our shop . however , simpich showcase is not able to work as a “middle man” for these repair procedures , and damaged dolls cannot be shipped or delivered to us before the repair work is done . in many cases , even major damage to a simpich figure can be addressed by a restoration specialist , but the cost for this must be discussed directly with her / him . unfortunately , simpich dolls that have been nearly destroyed by fire , smoke , flood or other extreme conditions cannot always be salvaged .
the following appears in the entry lobby to the simpich character dolls business , inside a wreath formed of many of bob and jan simpich ' s creations : note to gallery visitors : again jan and i wish to express to you our heartfelt appreciation for seeking our work and giving us the privilege and joy of creating all these editions . don ' t miss the message of hope and joy in them . it has been a wonderful life experience for us and we hope that you continue to receive pleasure from the pieces that you have acquired . jan and bob simpich
anecdotes from the early years can be found in the simpich catalog . in 1954 , when the first simpich angels were designed , “bob and jan sold an angel to purchase their christmas tree ( cost : $ 3 . 50 ) . ” in 1957 , they created dolls depicting characters from classic children ' s stories , including alice in wonderland , pinocchio and pecos bill . and in 1959 , after bob and jan had packed dolls on the floor for shipping , “sometimes orders were delivered to the bus station late at night , the dolls ' paint barely dry , ” the catalog states .
this is the simpich character doll
standing angel
. she has porcelain head , arms , feet , and wings . she is dressed in white and gold robes . she rises and is suspended above her white cloud . this doll . . .
simpich showcase welcomes excellently maintained simpich figures that you wish to consign into our store and online doll shop . once your dolls are approved and delivered to us , we will establish a price that is competitive in today’s market , but will maintain and / or advance the value of your figures in the secondary market . we will also handle the photography , sale and shipping of all figures . all consigned pieces must be in pristine condition– free of chips , stains , broken pieces and odors– for simpich showcase to offer them for final sale ( see our repairs section below for more info ) .
utilizing a full cast of hand - carved marionettes , frances hodgson burnett’s famous novel is staged in this live production by puppeteer david simpich .
the finished pieces have been sold locally from their store at 2413 w . colorado ave . and nationally from a catalog and website ( simpich . com ) .
sweet william
is part of the character elf series and features a cute little elf holding a sunflower . it stands 6
tall and is very nicely detailed . don ' t miss out on this opportunity to add to or s . . .
the employee dedication is one of the best parts of the story , according to the simpiches . staying open through this year meant giving the simpich workers more than a year ' s notice .
gabe
is part of the character elf series and features a cute little elf blowing on a hurn . it stands 6
tall and is very nicely detailed . don ' t miss out on this opportunity to add to or start your c . . .
been going here since i was a toddler . i am 37 now . this is a must see ! how in the world did it only get 3 stars . this is a 10 star establishment . thank you to the simpich family for such a wonderful gift to colorado !
over the years , the couple developed scores of characters from clay , with still more created by their sons , ragan and david . jan ' s signature pieces have been the younger - looking , more delicate dolls , such as “the standing angel , ” while bob has specialized in more wizened forms , such as his various elves or the recent “end of the line santa . ”
during the business ' early years , the couple did it all , working out of their house , with any help coming chiefly from family members . neither had studied pottery extensively . but when their improvised christmas presents in 1952 resulted in others seeing them and wanting dolls like them , the simpiches began creating more , and it grew from there . “we never set out to make a business , ” bob said .
this theater show is unlike anything i ' ve ever seen . truly very unique and very skilled . it is a one - man puppeteer show with marionettes and the detail of the dolls and scenery are fantastic . the skills of the performer are wonderful , very well done with an impressive range of voices , sound effects , lighting , and more . the show was filled with laughter and delight from the audience as well as chilling elements of drama . we saw a christmas carol and i would highly recommend it . i don ' t think it was overly religious like other reviewers complained about . just because a story has elements of christianity doesn ' t mean he ' s forcing it on you so i would tell the other reviewers to calm down and enjoy the art and unique skill in front of you . it is no easy task to put on such a unique show of skill by yourself with handmade marionette dolls of your own making .
the closing will vacate 2413 w . colorado ave . and the upstairs of 2411 ( the downstairs houses the holly berry house retail store ) . the two simpich - owned buildings , which together comprise nearly 11 , 000 square feet , are for sale . the asking price is $ 1 , 050 , 000 , according to travis bontrager of the realty firm of hoff & leigh .
the marionettes are incredible and worth checking out ( particularly the museum ) . they are simply breathtaking and a whole lot of fun to see . however , if you happen to be an atheist , beware of paying to see the christmas production simpich puts on each year . it ' s very religious - lots and lots of scripture and difficult for children to enjoy after about 20 minutes . even though we spent about $ 80 on our tickets , we left at intermission because it was just too over the top . just my opinion . others in this city will likely appreciate it more .
the business , which employs 45 people , has been located in old colorado city since 1978 .
the couple is ready for retirement , they said in a recent interview . “it ' s hard , ” jan conceded , but “when it ' s over , it ' s over . ”
classically trained artists , both plan to take a break from years of clay creations and spend more time on painting . bob , who was school district 11 ' s art director for 26 years already has a mural - esque group of paintings that is slated to hang in an area hospital .
the simpiches had originally wanted to close the business at the end of 2005 , but were flooded with so many orders they decided to stay with it another year . according to the website , sales had been “flat” for the past five years , so “we did not anticipate such a response . ”
even now , bob and jan are not sure that all orders can be filled ( the last were taken nov . 1 ) . “we ' ve been trying to fill orders all year , ” bob said . added jan , “we ' re doing the best we can , but we told them ( people who placed later orders ) that we couldn ' t guarantee anything . ”
“we were advised not to do it , ” bob said . people told them the employees would leave and find other jobs . instead , nearly all have stayed . even some who have found other jobs have continued to moonlight for the simpiches on a part - time basis .
they look back affectionately but critically on those earlier pieces , recalling their constant efforts over the years to improve technically and stylistically .
during this time , jan and bob had three children and they adopted another , while bob continued to work for district 11 .
the duo delayed the need for a commercial factory by fixing up where they lived . in 1955 , they built a work studio onto their manitou cabin ; in 1963 , they moved to a larger house on the westside ( where they still live , near the garden of the gods ) , and in 1975 they built a studio addition onto that house .
that worked until ' 78 , when they took the big plunge . synchronizing with bob ' s retirement from district 11 - which allowed him to work full - time on the family business - the simpiches moved their shop to the front part of the 2413 building in old colorado city and expanded production .
the space demands continued . first they expanded to the back of 2413 , then they bought 2411 , bob recalled .
young and disagreeable mary lennox is forced to stay at her uncle craven’s manor on the bleak yorkshire moors of northern england after the death of her parents . here she is drawn to a secluded garden surrounded by a high stone wall and with no apparent door or gate . when the entrance is miraculously revealed , mary’s exploration begins and the mysteries of her uncle’s manor are steadily brought to light .
initially , please call us at 719 . 465 . 2492 to discuss the pieces you are interested in consigning or fill out the form below . we will let you know if we can accept your pieces based on quality , your financial expectations and the space we have available in house . in some cases , we may be overstocked on certain figures , but will place your name and items on our waiting list to be approved , brought in or shipped to us at a later date .
sometimes a figure you might wish to consign with us cannot be approved because of a break , chip , stain or other repair need . many small repairs can be done in - house and any fees incurred will be taken off the final selling price .
lady with muff 12
( small chip to curl on reverse of her head . - man with lantern 14
( small chip on lantern . see the picture ) . - man with mandolin 13
. - little boy with snow ball 8
- man flute player 1 . . .
she has never been played with , but has been displayed for many years . therefore she is a bit dusty . there are no stains , but her wooden base does have a few scratches .
copyright © 1995 - 2018 ebay inc . all rights reserved . accessibility , user agreement , privacy , cookies and adchoice
this page was last updated : jul - 09 14 : 03 . number of bids and bid amounts may be slightly out of date . see each listing for international shipping options and costs .
first , try refreshing the page and clicking current location again . make sure you click allow or grant permissions if your browser asks for your location . if your browser doesn ' t ask you , try these steps :
at the top of your chrome window , near the web address , click the green lock labeled secure .
in the window that pops up , make sure location is set to ask or allow .
you ' re good to go ! reload this yelp page and try your search again .
if you ' re still having trouble , check out google ' s support page . you can also search near a city , place , or address instead .
at the top of your opera window , near the web address , you should see a gray location pin . click it .
if you ' re still having trouble , check out opera ' s support page . you can also search near a city , place , or address instead .
click safari in the menu bar at the top of the screen , then preferences .
under website use of location services , click prompt for each website once each day or prompt for each website one time only .
macos may now prompt you to enable location services . if it does , follow its instructions to enable location services for safari .
close the privacy menu and refresh the page . try using current location search again . if it works , great ! if not , read on for more instructions .
back in the privacy dialog , click manage website data . . . and type urltoken into the search bar .
you ' re good to go ! close the settings tab , reload this yelp page , and try your search again .
if you ' re still having trouble , check out safari ' s support page . you can also search near a city , place , or address instead .
at the top of your firefox window , to the left of the web address , you should see a green lock . click it .
in the window that pops up , you should see blocked or blocked temporarily next to access your location . click the x next to this line .
you ' re good to go ! refresh this yelp page and try your search again .
if you ' re still having trouble , check out firefox ' s support page . you can also search near a city , place , or address instead .
click the gear in the upper - right hand corner of the window , then internet options .
uncheck the box labeled never allow websites to request your physical location if it ' s already checked .
you ' re good to go ! click ok , then refresh this yelp page and try your search again .
at the top - right hand corner of the window , click the button with three dots on it , then settings .
click show more , then make sure only the box labeled location permissions is checked .
oops ! we don ' t recognize the web browser you ' re currently using . try checking the browser ' s help menu , or searching the web for instructions to turn on html5 geolocation for your browser . you can also search near a city , place , or address instead .
something broke and we ' re not sure what . try again later , or search near a city , place , or address instead .
we couldn ' t find you quickly enough ! try again later , or search near a city , place , or address instead .
we couldn ' t find an accurate position . if you ' re using a laptop or tablet , try moving it somewhere else and give it another go . or , search near a city , place , or address instead .
wonderful show , wonderful sole actor . we loved it . its not for small children , they won ' t have the patience . truly an art , and obvious he loves his performance . yes , it was religious but it was a christmas show ! the only negatives : there are only two stalls in the women ' s bathroom , so the show shouldn ' t start until everyone has had a chance to go because the theater is very dark . and the puppeteer ' s wife got up to hush a toddler who was not fussing or loud , he barely made a peep . the father left with him . i thought it was unnecessarily picky on her behalf . she needs a little more patience .
i went to see their christmas story show and i took my 11 year old nephew . we thought the puppets were awesome , but the story was very slow and repetitive and had only one actor who controlled all of the puppets and was mediocre in his performance . it would have been much better to have at least three actors controlling the puppets and doing the voices instead of just one man . the christmas story was badly written and it wasn ' t the real christmas story or very interesting . we left at intermission because we were bored . save your money and go see a movie instead . if they want to improve their productions , they need to hire more actors and make the stories much better and more compelling and interesting .
warning ! if you don ' t go to church don ' t go to this . there was no warning that the message was religion in the end . he is a great puppeteer and the actual beauty and the beast story was decent . i wish it could have just had the story i went to go see . it was good to see at least once .
your trust is our top concern , so businesses can ' t pay to alter or remove their reviews . learn more .
heads up : from now on , other yelpers will be able to see how you voted . want to chime in ?
we calculate the overall star rating using only reviews that our automated software currently recommends .
partly cloudy . a stray shower or thunderstorm is possible . low 71f . winds se at 5 to 10 mph . .
partly cloudy . a stray shower or thunderstorm is possible . low 71f . winds se at 5 to 10 mph .
oklahomans widely supported legalizing medical marijuana by passing state question 788 on june 26 . gov . mary fallin announced the same night she intends to work with legislators and the medical community to add regulations to the new legislation .
ou football : why j . d . runnels compared new sooner commit marcus major to adrian peterson
congress shall make no law respecting an establishment of religion , or prohibiting the free exercise thereof ; or abridging the freedom of speech , or of the press ; or the right of the people peaceably to assemble , and to petition the government for a redress of grievances .
© copyright 2018 norman transcript , 215 e . comanche st . norman , ok | terms of use | privacy policy